Welcome to our dedicated page for XBP Glo Hldg SEC filings (Ticker: XBPEW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for XBP Europe Holdings, Inc. (XBPEW) provides access to regulatory documents filed by XBP Global Holdings, Inc., the Delaware corporation whose common stock and redeemable warrants trade under the symbols XBP and XBPEW on Nasdaq. These filings offer detailed insight into the company’s business process automation activities, capital structure, and corporate governance.
Investors can review current reports on Form 8-K that describe material events, including the acquisition of Exela Technologies BPA, LLC, the related restructuring transactions, and the subsequent name change to XBP Global Holdings, Inc. Other 8-K filings discuss new credit facilities, exit financing arrangements, shareholder rights agreements, and changes in control status, giving readers a granular view of how the company has reshaped its balance sheet and ownership profile.
The filings set also includes proxy materials such as the Definitive Proxy Statement on Schedule 14A, which outlines proposals presented to stockholders, including increases in authorized share capital, amendments to the charter and bylaws, a potential reverse stock split, and amendments to stock incentive plans. These documents explain how the board approaches governance, capital raising, and equity compensation.
Regulatory disclosures further cover Nasdaq listing and compliance matters. For example, an 8-K dated September 16, 2025, reports receipt of a Nasdaq deficiency letter regarding the minimum bid price requirement for the common stock and describes the compliance period and potential consequences if the issue is not resolved. Such filings are important for understanding listing status and related risks for both XBP shares and XBPEW warrants.
Through Stock Titan, users can view these filings as they are made available from EDGAR and use AI-powered summaries to interpret complex sections, such as transaction support agreements, membership interest purchase agreements, and financing documents. This helps readers quickly identify key terms, obligations, and potential impacts on shareholders and warrant holders without having to parse every technical detail manually.
XBP Global Holdings, Inc. describes its 2025 operations as a multinational technology and services company that powers intelligent, AI-driven workflows for more than 2,500 clients across highly regulated sectors such as healthcare, banking, insurance and the public sector.
For 2025 the Predecessor period from January 1 to July 31 generated $431.7 million of revenue and the Successor period from August 1 to December 31 generated $359.4 million, with about 90% of combined revenue from the United States. Healthcare contributed about 28% of 2025 revenue, banking and financial services 19%, and public sector work 11%.
The report explains the July 29, 2025 Business Combination in which XBP acquired BPA, which had just emerged from Chapter 11 reorganization, creating a global platform spanning the Americas, EMEA and Asia. It also notes a one-for-ten reverse stock split completed on December 12, 2025, leaving 11,768,050 common shares outstanding as of March 30, 2026.
Management highlights a strategic focus on agentic AI, robotic process automation, digital mailroom, workflow automation, and industry-specific platforms such as PCH Global for healthcare revenue cycle management and the XBP exchange for bills and payments. As of December 31, 2025 the company had about 10,600 employees in 20 countries and relatively low client concentration, with its top five clients accounting for 27% of 2025 revenue and no single client exceeding 10%.
XBP Global Holdings, Inc. reported fourth quarter and full year 2025 results reflecting a major transition after acquiring Exela Technologies BPA. As reported full year 2025 revenue was $791.0 million, down from $872.7 million, while pro forma revenue was $879.6 million versus $1,017.6 million. As reported full year gross margin held near 21.7%, and pro forma gross margin was 21.9%. Fourth quarter 2025 revenue was $207.0 million, down 15.1% year over year, with gross margin improving to 22.7%. The company recorded a successor-period net loss of $351.1 million, driven largely by a $320.3 million goodwill impairment, while full year pro forma normalized EBITDA reached $90.2 million. Management highlighted sales investments and agentic AI-driven automation aimed at stabilizing the acquired business and supporting future growth.
XBP Global Holdings, Inc. disclosed that subsidiary XBP Americas, LLC entered into a Limited Waiver and Third Amendment to its asset-based Credit and Security Agreement on March 6, 2026. The amendment removes the covenant requiring minimum excess availability of $7.5 million.
The Third Amendment adds a temporary availability block through June 30, 2026, reducing borrowing capacity by the greater of $3.75 million or 5.0% of the borrowing base if the fixed charge coverage ratio falls below 1.00 to 1.00. It also temporarily raises the advance rate on eligible investment grade billed accounts to 95.0% through September 30, 2026 and adjusts borrowing base calculations, cash dominion mechanics, and the deferred revolving loan origination fee.
XBP Global Holdings, Inc. reported that it received a Nasdaq deficiency notice because the closing bid price of its common stock stayed below $1.00 for 30 consecutive business days from August 4 to September 15, 2025, violating Nasdaq’s minimum bid price rule. The company has a 180-day grace period, until March 16, 2026, to regain compliance by having its closing bid price at or above $1.00 for at least ten consecutive business days, a period Nasdaq may extend in certain cases. XBP notes that recent closing bid prices have been above $1.00 but cautions there is no assurance it will regain or maintain compliance. If it fails to do so, its stock could be delisted, though the company would have appeal rights. For now, the common stock and publicly traded warrants continue trading on the Nasdaq Capital Market under the symbols XBP and XBPW.
Avenue-affiliated funds disclosed significant ownership in XBP Global Holdings (XBP). Multiple Avenue entities report beneficial ownership of common stock: 6,564,883 shares, 4,082,116 shares and 1,460,908 shares across three funds. The filings state registered advisers have sole voting and dispositive power for those funds, while certain entities and Marc Lasry disclaim beneficial ownership except for any pecuniary interest.
XBP Global Holdings, Inc. filed an amended current report to add detailed financial information for its recent acquisition of Exela Technologies BPA, LLC and its subsidiaries, referred to as the BPA Group.
The amendment incorporates audited BPA Group financial statements for the years ended December 31, 2024 and 2023, unaudited interim results for the three months ended March 31, 2025, and unaudited pro forma condensed combined financial information as of and for the three-month period ended March 31, 2025. These materials are incorporated by reference from the company’s definitive proxy statement, and the filing also includes an auditor consent from EisnerAmper LLP.
Reporting person: Par Chadha, a director of XBP Global Holdings, Inc. (symbol XBPEW). On 09/09/2025 Mr. Chadha was granted 205,858 RSUs under the companys 2024 Stock Incentive Plan; those RSUs are scheduled to vest in full on August 1, 2026. The filing reports multiple indirect holdings controlled by the reporting person, including reported beneficial ownership figures of 1,534,146, 1,128,972, and 27,037,562 shares of common stock held by entities the reporting person controls. The filing also discloses warrants to purchase 6,632,418 shares exercisable at $4.98 expiring 07/29/2030. The Form is signed and dated 09/11/2025.
James Reynolds, a director of XBP Global Holdings, Inc., was granted 205,858 restricted stock units (RSUs) on 09/09/2025 at a $0 price. The RSUs are scheduled to vest in full on August 1, 2026. After the grant, the reporting person beneficially owns 440,715 shares. The Form 4 was signed by an attorney-in-fact on 09/11/2025. The filing shows this transaction was reported as an acquisition of common stock units under the company plan and does not report any cash purchase price.
Regina Paolillo, a director of XBP Global Holdings, Inc. (XBP), was granted 205,858 restricted stock units (RSUs) on 09/09/2025 under the company's 2024 Stock Incentive Plan. The RSUs were issued at no cash price and are reported as directly beneficially owned, totaling 205,858 shares following the grant. The RSUs are scheduled to vest in full on August 1, 2026. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Paolillo on 09/11/2025. This filing records a standard equity compensation grant to a director and specifies the vesting date and plan under which the award was made.
Insider grant recorded: Sanjay Srivastava, identified as a director of XBP Global Holdings, Inc., was granted 205,858 restricted stock units (RSUs) on 09/09/2025 at no cash price. The RSUs were issued under the companys 2024 Stock Incentive Plan, as amended, and are scheduled to vest in full on August 1, 2026. The Form 4 was signed on behalf of Mr. Srivastava by an attorney-in-fact, Ross Dawson, on 09/11/2025. The filing indicates direct beneficial ownership following the transaction of 205,858 shares and lists the reporting persons address as C/O XBP Global Holdings, Inc., Irving, TX.